CNCR

ETF Series Solutions Trust Range Cancer Therapeutics ETF

Delisted

CNCR was delisted on the 27th of May, 2025.

21 hedge funds and large institutions have $15.1M invested in ETF Series Solutions Trust Range Cancer Therapeutics ETF in 2020 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 6 increasing their positions, 7 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

more ownership

Funds ownership:

more capital invested

Capital invested by funds: $ → $

more funds holding

Funds holding:

more funds holding in top 10

Funds holding in top 10:

0% more first-time investments, than exits

New positions opened: 1 | Existing positions closed: 1

14% less repeat investments, than reductions

Existing positions increased: 6 | Existing positions reduced: 7

Holders
21
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
1
$9.19M
2
$945K
3
$892K
4
$675K
5
$584K
6
$529K
7
$484K
8
$466K
9
$367K
10
$255K
11
$241K
12
$167K
13
$127K
14
$71.4K
15
$51K
16
$34K
17
$27K
18
$11K
19
$8K
20
$5K
21
$1K